Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents

Abstract

Aims/hypothesis Type 2 diabetes is characterised by progressive loss of pancreatic beta cell mass and function. Therefore, it is of therapeutic interest to identify factors with the potential to improve beta cell proliferation and insulin secretion. Bone morphogenetic protein 4 (BMP4) expression is increased in diabetic animals and BMP4 reduces glucose-stimulated insulin secretion (GSIS). Here, we investigate the molecular mechanism behind this inhibition. Methods BMP4-mediated inhibition of GSIS was investigated in detail using single cell electrophysiological measurements and live cell Ca 2+ imaging. BMP4-mediated gene expression changes were investigated by microarray profiling, quantitative PCR and western blotting.Results Prolonged exposure to BMP4 reduced GSIS from rodent pancreatic islets. This inhibition was associated with decreased exocytosis due to a reduced Ca 2+ current through voltage-dependent Ca 2+ channels. To identify proteins involved in the inhibition of GSIS, we investigated global gene expression changes induced by BMP4 in neonatal rat pancreatic islets. Expression of the Ca 2+ -binding protein calbindin1 was significantly induced by BMP4. Overexpression of calbindin1 in primary islet cells reduced GSIS, and the effect of BMP4 on GSIS was lost in islets from calbindin1 (Calb1) knockout mice. Conclusions/interpretation We found BMP4 treatment to markedly inhibit GSIS from rodent pancreatic islets in a calbindin1-dependent manner. Calbindin1 is suggested to mediate the effect of BMP4 by buffering Ca 2+ and decreasing Ca 2+ channel activity, resulting in diminished insulin exocytosis. Both BMP4 and calbindin1 are potential pharmacological targets for the treatment of beta cell dysfunction.

Dual Effect of Rosuvastatin on Glucose Homeostasis Through Improved Insulin Sensitivity and Reduced Insulin Secretion

“…The impaired Ca 2 + response and particularly the reduced re-uptake of Ca 2 + to ER in rosuvastatin treated mice prompted us to investigate the expression of ER-related genes; SERCA2 , SERCA3 , Sel1l and CHOP (Chen et al, 2014, Francisco et al, 2011, Ravier et al, 2011) together with Calb1 , a gene we previously suggested to be involved in Ca 2 + buffering (Christensen et al, 2015). Rosuvastatin reduced the expression of CHOP in mice on ND, but had no effect on the expression of the other genes investigated (Fig.…”

A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort

“…With the addition of DM2 as a covariate, the GWAS identified several additional SNPs on chromosome 8, as well as SNPs on chromosomes 17 and 19. These additional SNPs were previously linked to BMI and obesity in other studies (Christensen et al 2015;Nakajima et al 2016;Thomsen et al 2016). Manhattan plots for the two BMI GWAS studies are presented in Figure 1 and Supplementary Figure S2, with the linear associations results presented in Table 3.…”

Serotonin (5-HT) receptor 2b activation augments glucose-stimulated insulin secretion in human and mouse islets of Langerhans

“…Fura 2-AM (4 μmol/l) (TEFLabs, Austin, TX, USA) were applied for 40 min followed by 30 min of de-esterification in imaging buffer. Imaging was performed as previously described [31]. One frame per second was recorded at 37°C under perfusion at 0.7 ml/min for 5 min at 2.8 mmol/l glucose, followed by 20 min at 16.7 mmol/l glucose, then 20 min at 2.8 mmol/l glucose with or without AMS.…”